Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7
Palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7 are the fatty-acid-tagged peptide pair formulated together as Matrixyl 3000, and the most useful recent measurement shows where they actually go: into every layer of the stratum corneum, but between the cells rather than inside them.
Both molecules follow the same design logic: a short signal-type peptide with a palmitic acid chain attached to the N-terminus to make it more lipophilic. Palmitoyl tripeptide-1 is palmitoyl-glycyl-histidyl-lysine, and palmitoyl tetrapeptide-7 is Pal-GQPR (palmitoyl-glycyl-glutaminyl-prolyl-arginine). The palmitoyl tag is the reason they are expected to cross the outer skin barrier at all, which made direct measurement the open question.
That measurement now exists. Trzaska et al., International Journal of Pharmaceutics, 2026 (PMID 42790608) applied a serum containing the pair to three volunteers for 0.5, 2 and 5 hours, tape-stripped the stratum corneum and imaged it with OrbiSIMS mass spectrometry. Both peptides were detected throughout every stripped layer, with signal falling with depth and no significant change across exposure times. Depth profiles dropped immediately, which the authors read as an intercellular route, on cell surfaces rather than inside corneocytes, and they concluded that lipophilicity alone does not predict the pathway.
Quantifying these peptides in a finished product is its own problem. Chirita et al., Analytica Chimica Acta, 2009 (PMID 19393372) developed an LC-MS/MS method that detects palmitoyl peptides in anti-wrinkle creams after liquid-liquid extraction, using palmitoyl-glycyl-histidyl-lysine as the internal standard for assaying pal-KTTKS, and showed that the formulation itself changes how much peptide is available.
The efficacy literature is thinner than the shelf presence. Resende et al., Pharmaceuticals, 2021 (PMID 34451799) reviewed 88 facial products for sensitive skin, found peptides in 17% of them, palmitoyl tetrapeptide-7 among them, and noted that the supporting data sit mostly in patents and supplier brochures rather than randomized placebo-controlled studies. The related matrix-signal peptide is covered in Palmitoyl Pentapeptide-4. This note summarizes published analytical and skin-permeation research. It is not skincare, dosing, or human-use guidance.